Indication

Anterior

1 clinical trial

1 product

Clinical trial

A 24-week Two-armed Proof-of-concept Exploratory Analysis of Subcutaneous Ixekizumab Administration in Patients With Recalcitrant Non-infectious Intermediate, Posterior, Panuveitis, or Chronic Steroid-dependent Anterior Uveitis.

Status: Recruiting, Estimated PCD: 2024-12-30

Product